BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 24339177)

  • 1. Cell surface protein glycosylation in cancer.
    Christiansen MN; Chik J; Lee L; Anugraham M; Abrahams JL; Packer NH
    Proteomics; 2014 Mar; 14(4-5):525-46. PubMed ID: 24339177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma.
    Ho WL; Hsu WM; Huang MC; Kadomatsu K; Nakagawara A
    J Hematol Oncol; 2016 Sep; 9(1):100. PubMed ID: 27686492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A glycomics approach to the discovery of potential cancer biomarkers.
    An HJ; Lebrilla CB
    Methods Mol Biol; 2010; 600():199-213. PubMed ID: 19882130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between the branch-forming glycosyltransferases and cell surface sugar chain structures.
    Takamatsu S; Inoue N; Katsumata T; Nakamura K; Fujibayashi Y; Takeuchi M
    Biochemistry; 2005 Apr; 44(16):6343-9. PubMed ID: 15835923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-linked mucin-type glycosylation in breast cancer.
    Burchell JM; Beatson R; Graham R; Taylor-Papadimitriou J; Tajadura-Ortega V
    Biochem Soc Trans; 2018 Aug; 46(4):779-788. PubMed ID: 29903935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modification of glycoconjugates during the carcinogenesis: the case of mammary carcinomas].
    Guillot J; Guerry M; Konska G; Caldefie-Chezet F; De Latour M; Penault-Llorca F
    Bull Cancer; 2004 Feb; 91(2):141-58. PubMed ID: 15047454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of altered glycoprotein-bound N- and O-glycans for epithelial-to-mesenchymal transition and adhesion of cancer cells.
    Lange T; Samatov TR; Tonevitsky AG; Schumacher U
    Carbohydr Res; 2014 May; 389():39-45. PubMed ID: 24491280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The analysis of N-glycans of cell membrane proteins from human hematopoietic cell lines reveals distinctions in their pattern.
    Reinke SO; Bayer M; Berger M; Hinderlich S; Blanchard V
    Biol Chem; 2012 Aug; 393(8):731-47. PubMed ID: 22944676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pattern of glycosyl- and sulfotransferase activities in cancer cell lines: a predictor of individual cancer-associated distinct carbohydrate structures for the structural identification of signature glycans.
    Chandrasekaran EV; Xue J; Neelamegham S; Matta KL
    Carbohydr Res; 2006 Jun; 341(8):983-94. PubMed ID: 16545347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-AZA-2'-deoxycytidine induced demethylation influences N-glycosylation of secreted glycoproteins in ovarian cancer.
    Saldova R; Dempsey E; Pérez-Garay M; Mariño K; Watson JA; Blanco-Fernández A; Struwe WB; Harvey DJ; Madden SF; Peracaula R; McCann A; Rudd PM
    Epigenetics; 2011 Nov; 6(11):1362-72. PubMed ID: 22086115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The alteration of proteins glycosylation in liver diseases].
    Chrostek L; Cylwik B
    Pol Merkur Lekarski; 2011 Jul; 31(181):60-4. PubMed ID: 21870713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycans as cancer biomarkers.
    Adamczyk B; Tharmalingam T; Rudd PM
    Biochim Biophys Acta; 2012 Sep; 1820(9):1347-53. PubMed ID: 22178561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, β1-4 Branching, β1-6 Branching, and α2-6 Sialylation in Cancer.
    Ferdosi S; Rehder DS; Maranian P; Castle EP; Ho TH; Pass HI; Cramer DW; Anderson KS; Fu L; Cole DEC; Le T; Wu X; Borges CR
    J Proteome Res; 2018 Jan; 17(1):543-558. PubMed ID: 29129073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different glycosyltransferases are involved in lipid glycosylation and protein N-glycosylation in the halophilic archaeon Haloferax volcanii.
    Naparstek S; Vinagradov E; Eichler J
    Arch Microbiol; 2010 Jul; 192(7):581-4. PubMed ID: 20458469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive clinico-glycomic study of 16 colorectal cancer specimens: elucidation of aberrant glycosylation and its mechanistic causes in colorectal cancer cells.
    Misonou Y; Shida K; Korekane H; Seki Y; Noura S; Ohue M; Miyamoto Y
    J Proteome Res; 2009 Jun; 8(6):2990-3005. PubMed ID: 19292502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant sialylation and fucosylation of intracellular proteins in cervical tissue are critical markers of cervical carcinogenesis.
    Kim HJ; Kim SC; Ju W; Kim YH; Yin SY; Kim HJ
    Oncol Rep; 2014 Mar; 31(3):1417-22. PubMed ID: 24366620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical and biological strategies for engineering cell surface glycosylation.
    Saxon E; Bertozzi CR
    Annu Rev Cell Dev Biol; 2001; 17():1-23. PubMed ID: 11687482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor cell N-glycans in metastasis.
    Laidler P; Lityńska A
    Acta Biochim Pol; 1997; 44(2):343-57. PubMed ID: 9360725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in glycosylation as biomarkers for cancer detection.
    Reis CA; Osorio H; Silva L; Gomes C; David L
    J Clin Pathol; 2010 Apr; 63(4):322-9. PubMed ID: 20354203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional roles of N-glycans in cell signaling and cell adhesion in cancer.
    Zhao YY; Takahashi M; Gu JG; Miyoshi E; Matsumoto A; Kitazume S; Taniguchi N
    Cancer Sci; 2008 Jul; 99(7):1304-10. PubMed ID: 18492092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.